digplanet beta 1: Athena
Share digplanet:


Applied sciences






















CHO cells adhered to a surface, seen under Phase Contrast Microscopy

Chinese hamster ovary (CHO) cells are a cell line derived from the ovary of the Chinese hamster, often used in biological and medical research and commercially in the production of therapeutic proteins.[1] They have found wide use in studies of genetics, toxicity screening, nutrition and gene expression, particularly to express recombinant proteins. CHO cells are the most commonly used mammalian hosts for industrial production of recombinant protein therapeutics.[1]


The Chinese hamster had been used in research since 1919 where they were used in place of mice for typing pneumococci. They were subsequently found to be excellent vectors for transmission of kala-azar (a.k.a. visceral leishmaniasis), facilitating leishmania research.

In 1948, the Chinese hamster was brought to the United States for breeding in research laboratories. In 1957, Theodore T. Puck obtained a female Chinese hamster from Dr. George Yerganian's laboratory at the Boston Cancer Research Foundation and used it to derive the original Chinese hamster ovary (CHO) cell line. Since then, CHO cells have been a cell line of choice because of their rapid growth in suspension culture and high protein production.

Having a very low chromosome number (2n=22) for a mammal, the Chinese hamster is also a good model for radiation cytogenetics and tissue culture.[2]


All CHO cell lines are deficient in proline synthesis.[3] Also CHO cells do not express the Epidermal growth factor receptor (EGFR), which makes them ideal in the investigation of various EGFR mutations.[4]


Since the original CHO cell line was described in 1956, many variants of the cell line have been developed for various purposes.[3] In 1957, CHO-K1 was generated from a single clone of CHO cells,[5] CHO-K1 was mutagenized with ethyl methanesulfonate to generate a cell line lacking DHFR activity, referred to as CHO-DXB11 (also referred to as CHO-DUKX).[6] However these cells, when mutagenized, could revert to DHFR activity, making their utility for research somewhat limited.[6] Subsequently, CHO cells were mutagenized with gamma radiation to yield a cell line in which both alleles of the DHFR locus were completely eliminated, termed CHO-DG44[7] These DHFR-deficient strains require glycine, hypoxanthine, and thymidine for growth.[7] Cell lines with mutated DHFR are useful for genetic manipulation as cells transfected with a gene of interest along with a functional copy of the dhfr gene can easily be screened for in thymidine-lacking medium. Due to this, CHO cells lacking DHFR are the most widely used CHO cells for industrial protein production.[3]

Genetic Manipulation[edit]

Much of the genetic manipulation done in CHO cells is done in cells lacking DHFR (see Chinese hamster ovary cell#Variants). [3] This genetic selection scheme remains one of the standard methods to establish transfected CHO cell lines for the production of recombinant therapeutic proteins. The process begins with the molecular cloning of the gene of interest and the dhfr gene into a single mammalian expression system. The plasmid DNA carrying the two genes is then transfected into cells, and the cells are grown under selective conditions in thymidine-lacking medium. Surviving cell will have the exogenous DHFR gene along with the gene of interest integrated in its genome.[8][9] The growth rate and the level of recombinant protein production of each cell line vary widely. To obtain a few stably transfected cell lines with the desired phenotypic characteristics, it may be necessary to evaluate several hundred candidate cell lines.

The CHO and CHO-K1 cell lines can be obtained from a number of biological resource centres such as the European Collection of Cell Cultures (ECACC) which is part of the Health Protection Agency Culture Collections. These organizations also maintain data, such as growth curves, timelapse videos of growth, images and subculture routine information.[10]

Industrial Use[edit]

CHO cells are the most common mammalian cell line used for mass production of therapeutic proteins.[1] They can produce recombinant protein on the scale of 3-10 grams per liter of culture.[3]

See also[edit]


  1. ^ a b c Wurm FM (2004). "Production of recombinant protein therapeutics in cultivated mammalian cells". Nature Biotechnology 22: 1393–1398. doi:10.1038/nbt1026. 
  2. ^ Tjio J. H., Puck T. T., (1958). "Genetics of somatic mammalian cells. II. chromosomal constitution of cells in tissue culture.". J. Exp. Med. 108: 259–271. doi:10.1084/jem.108.2.259. PMC 2136870. PMID 13563760. 
  3. ^ a b c d e Wurm FM; Hacker D (2011). "First CHO genome". Nature Biotechnology 29: 718–20. doi:10.1038/nbt.1943. PMID 21822249. 
  4. ^ Ahsan, A.; S. M. Hiniker; M. A. Davis; T. S. Lawrence; M. K. Nyati (2009). "Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated Radiosensitization". Cancer Research 69 (12): 5108–5114. doi:10.1158/0008-5472.CAN-09-0466. PMID 19509222. 
  5. ^ Lewis NE; Liu X; Li Y; Nagarajan H; Yerganian G; O'Brien E; et al. (2013). "Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome". Nature Biotechnology 31 (8): 759–765. doi:10.1038/nbt.2624. PMID 23873082. 
  6. ^ a b Urlaub G; Chasin LA (July 1980). "Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity". Proceedings of the National Academy of Sciences U.S.A. 77 (7): 4216–4220. PMC 349802. 
  7. ^ a b Urlaub G; Kas E; Carothers AD; Chasin LA (June 1983). "Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells". Cell 33 (2): 405–412. PMID 6305508. 
  8. ^ Lee F; Mulligan R; Berg P; Ringold G (19 November 1981). "Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids". Nature 294 (5838): 228–232. PMID 6272123. 
  9. ^ Kaufman RJ; Sharp PA (25 August 1982). "Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene". Journal of Molecular Biology 159 (4): 601–621. PMID 6292436. 
  10. ^ "General Cell Collection: CHO-K1". Hpacultures.org.uk. 2000-01-01. Retrieved 2013-05-21. 

External links[edit]

Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.

53 news items


Wed, 27 Apr 2016 20:22:30 -0700

這座工廠是一棟古色古香的建築,廠內有容量4000公升的生物反應器(bioreactor),培養用來製造Myozyme的中國倉鼠卵巢細胞(Chinese hamster ovary cell, CHO cell),現在這個藥物每年的產值高達7億5000萬美元,但是營收所產生的利潤,並沒有全部納入中橡轉 ...
JAMA: The Journal of the American Medical Association
Tue, 19 Jan 2016 08:08:49 -0800

Vonicog alfa, marketed as Vonvendi, is produced with a genetically engineered Chinese hamster ovary cell line that expresses von Willebrand factor and the blood-clotting protein factor VIII. Even though von Willebrand disease affects about 1% of the US ...

The Pharma Letter (registration)

The Pharma Letter (registration)
Wed, 16 Sep 2015 04:36:14 -0700

UK-based Horizon Discovery (LSE: HZD) on Wednesday said it has, via its bioproduction arm, signed a license agreement with LakePharma for commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line. No financial details were ...

Medical Xpress

Medical Xpress
Fri, 11 Sep 2015 05:49:54 -0700

The researchers compared four 2A peptides, both in the presence and absence of glycine-serine-glycine linkers, used to express three bio-similar Immunoglobulin G 1 monoclonal antibodies in Chinese hamster ovary cell lines via transient and stable ...
Tue, 09 Dec 2014 00:48:41 -0800

Horizon Discovery Group announced Monday that its bioproduction division has shipped its first commercially available engineered CHO (Chinese Hamster Ovary) cell line for use in manufacturing of antibodies.

InvestorIdeas.com (press release)

InvestorIdeas.com (press release)
Wed, 09 Sep 2015 12:41:15 -0700

The same regulations apply to us that apply to E. coli fermenters, CHO (Chinese hamster ovary) cell bioreactors or other manufacturing methods. Many people think there are hurdles because only one plant-based recombinant therapeutic has been ...


Mon, 27 Apr 2015 07:20:55 -0700

After a long pause, the clinical development of soluble rhuFlt3L (now designated CDX-301) has been reinitiated using a new manufacturing process including a proprietary Chinese hamster ovary cell production line and serum-free cell culture. CDX-301 was ...
Mondaq News Alerts (registration)
Tue, 10 Mar 2015 05:36:57 -0700

The PTAB found that a person of ordinary skill would have been motivated to make this combination and that the claimed methods employing GAA "produced in chinese hamster ovary cell cultures" were obvious. The Myozyme® patents are just three of a ...

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight